# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-017709
Filing Date
2017-03-30
Accepted
2017-03-30 16:28:27
Documents
55
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | v462622_10k.htm | 10-K | 672214
2 | EXHIBIT 21 | v462622_ex21.htm | EX-21 | 1710
3 | EXHIBIT 23.1 | v462622_ex23-1.htm | EX-23.1 | 2490
4 | EXHIBIT 31.1 | v462622_ex31-1.htm | EX-31.1 | 10720
5 | EXHIBIT 31.2 | v462622_ex31-2.htm | EX-31.2 | 11417
6 | EXHIBIT 32 | v462622_ex32.htm | EX-32 | 5095
| Complete submission text file | 0001144204-17-017709.txt |  | 5162871

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENT | accp-20161231.xml | EX-101.INS | 1065985
8 | XBRL TAXONOMY EXTENSION SCHEMA | accp-20161231.xsd | EX-101.SCH | 37865
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | accp-20161231_cal.xml | EX-101.CAL | 66573
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | accp-20161231_def.xml | EX-101.DEF | 237327
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | accp-20161231_lab.xml | EX-101.LAB | 640025
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | accp-20161231_pre.xml | EX-101.PRE | 370527

Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 17726106
SIC: 2834 Pharmaceutical Preparations